Patients on oral oncolytics are put in a position of greater autonomy, accountability, and responsibility, but is it patient centered? While some patients may appreciate a sense of empowerment, we find patients with advanced disease are overwhelmed by the adverse effects and complicated regimens. It appears that often our systems make a tacit assumption that patients will proceed with treatment without full discussion of benefits versus costs and toxicities. If these drugs are effective molecularly, what is the impact on the patient_s emotional status and physical status and patient centeredness? Understanding patients_ response and needed support to this complex new approach to treatment is essential. We need to develop evidence so that guidelines and standards of care can be tested, translated, and implemented in clinical settings. We need to know what guidance patients need to be supported to initiate and continue treatment. The nursing science of care needs to catch up with this treatment approach.
